TrivarX Partners with Syntro Health for Stabl-Im Formulation Ahead of 2027 Clinical Trial - Kalkine Media

This is a short summary. The full story is published by Kalkine Media.
Read full story at Kalkine MediaLooking for pharma deals? Explore marketplace now Explore

This is a short summary. The full story is published by Kalkine Media.
Read full story at Kalkine Media
EMA’s Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely start of…

The Prime Minister’s father Roy died with Alzheimer’s disease in September.

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer…
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
Exclusive introductory offer for new advertisers
Get offers from suppliers
Your product details and requirements may be published on the marketplace.
Fields marked with * are mandatory.